These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21788602)

  • 21. Comparison of the effects of doxazosin and atenolol on target organ damage in adults with type 2 diabetes mellitus and hypertension in the CARDHIAC study: a 9-month, prospective, randomized, open-label, blinded-evaluation trial.
    Barrios V; Escobar C; Tomás JP; Calderon A; Echarri R
    Clin Ther; 2008 Jan; 30(1):98-107. PubMed ID: 18343246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased arterial intima-media thickness and in vivo LDL oxidation in young men with borderline hypertension.
    Toikka JO; Laine H; Ahotupa M; Haapanen A; Viikari JS; Hartiala JJ; Raitakari OT
    Hypertension; 2000 Dec; 36(6):929-33. PubMed ID: 11116102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arterial stiffness and left ventricular diastolic function in the patients with hypertension.
    Agoşton-Coldea L; Mocan T; Bobar C
    Rom J Intern Med; 2008; 46(4):313-21. PubMed ID: 19480297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
    Soliman EZ; Ambrosius WT; Cushman WC; Zhang ZM; Bates JT; Neyra JA; Carson TY; Tamariz L; Ghazi L; Cho ME; Shapiro BP; He J; Fine LJ; Lewis CE;
    Circulation; 2017 Aug; 136(5):440-450. PubMed ID: 28512184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of low-and high-density lipoprotein cholesterol levels on carotid intima-media thickness differs by smoking status in middle-aged men.
    Hayase T; Ayaori M; Sato H; Tanaka N; Ohashi K; Uto-Kondo H; Ikewaki K; Ohsuzu F
    J Atheroscler Thromb; 2012; 19(7):664-72. PubMed ID: 22498769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008.
    Kuznik A; Mardekian J
    Cardiovasc Diabetol; 2011 Apr; 10():31. PubMed ID: 21496321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness.
    Taylor AJ; Kent SM; Flaherty PJ; Coyle LC; Markwood TT; Vernalis MN
    Circulation; 2002 Oct; 106(16):2055-60. PubMed ID: 12379573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal association of ambulatory pulse pressure with left ventricular mass and vascular hypertrophy in essential hypertension.
    Khattar RS; Acharya DU; Kinsey C; Senior R; Lahiri A
    J Hypertens; 1997 Jul; 15(7):737-43. PubMed ID: 9222941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood pressure, LDL cholesterol, and intima-media thickness: a test of the "response to injury" hypothesis of atherosclerosis.
    Sun P; Dwyer KM; Merz CN; Sun W; Johnson CA; Shircore AM; Dwyer JH
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2005-10. PubMed ID: 10938024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Which factors are related to the presence of atherosclerosis in rheumatoid arthritis?
    Wållberg-Jonsson S; Ohman M; Rantapää-Dahlqvist S
    Scand J Rheumatol; 2004; 33(6):373-9. PubMed ID: 15794194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of candesartan cilexetil on carotid remodeling in hypertensive diabetic patients: the MITEC study.
    Baguet JP; Asmar R; Valensi P; Nisse-Durgeat S; Mallion JM
    Vasc Health Risk Manag; 2009; 5(1):175-83. PubMed ID: 19436670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics and lipid distribution of a large, high-risk, hypertensive population: the lipid-lowering component of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Papademetriou V; Piller LB; Ford CE; Gordon D; Hartney TJ; Geraci TS; Reisin E; Sumner BM; Wong ND; Nwachuku C; Narayan P; Haywood J; Habib G;
    J Clin Hypertens (Greenwich); 2003; 5(6):377-84. PubMed ID: 14688492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central or peripheral systolic or pulse pressure: which best relates to target organs and future mortality?
    Wang KL; Cheng HM; Chuang SY; Spurgeon HA; Ting CT; Lakatta EG; Yin FC; Chou P; Chen CH
    J Hypertens; 2009 Mar; 27(3):461-7. PubMed ID: 19330899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy.
    Yan X; Li Y; Dong Y; Wu Y; Li J; Bian R; Hu D
    Lipids Health Dis; 2019 Jan; 18(1):32. PubMed ID: 30696435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The VYtorin on Carotid intima-media thickness and overall arterial rigidity (VYCTOR) study.
    Meaney A; Ceballos G; Asbun J; Solache G; Mendoza E; Vela A; Meaney E
    J Clin Pharmacol; 2009 Jul; 49(7):838-47. PubMed ID: 19443679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycaemic, blood pressure and cholesterol control in 25 629 diabetics.
    Pinchevsky Y; Butkow N; Chirwa T; Raal FJ
    Cardiovasc J Afr; 2015; 26(4):188-92. PubMed ID: 26407221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, double-blind study.
    Derosa G; Cicero AF; Bertone G; Piccinni MN; Fogari E; Ciccarelli L; Fogari R
    Clin Ther; 2004 Aug; 26(8):1228-36. PubMed ID: 15476904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Impact of the presence of cardiovascular disease on blood pressure and lipid control in the hypertense population attended in primary care].
    Barrios Alonso V; Escobar Cervantes C; Calderón Montero A; Llisterri Caro JL; Echarri Carrillo R; Matalí A
    Aten Primaria; 2008 Jan; 40(1):21-7. PubMed ID: 18190764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations of TSH levels within the reference range with future blood pressure and lipid concentrations: 11-year follow-up of the HUNT study.
    Asvold BO; Bjøro T; Vatten LJ
    Eur J Endocrinol; 2013 Jul; 169(1):73-82. PubMed ID: 23641017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [LDL-cholesterol in secondary prevention: goal-attainment in patients on lipid-lowering drugs in private practice and in hospitals in Austria (ZIEL)].
    Föger B; Patsch JR
    Wien Klin Wochenschr; 2011 Jan; 123(1-2):21-7. PubMed ID: 21165704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.